The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Targeting Raf Kinase Inhibitory Protein Regulation and Function
Abstract
Raf Kinase Inhibitory Protein (RKIP) is a highly conserved kinase inhibitor that functions as a metastasis suppressor in a variety of cancers. Since RKIP can reprogram tumor cells to a non-metastatic state by rewiring kinase networks, elucidating the mechanism by which RKIP acts not only reveals molecular mechanisms that regulate metastasis, but also represents an opportunity to target these signaling networks therapeutically. Although RKIP is often lost during metastatic progression, the mechanism by which this occurs in tumor cells is complex and not well understood. In this review, we summarize our current understanding of RKIP regulation in tumors and consider experimental and computational strategies for recovering or mimicking its function by targeting mediators of metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RKIP is a member of the highly conserved phosphatidylethanolamine binding protein (PEBP) family and regulates key kinase pathways such as the Raf/MAPK pathway and β-AR/cAMP–dependent protein kinase A (PKA) signaling cascade (2, 3).”
From Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop (2022) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duncan, J. S., Whittle, M. C., Nakamura, K., Abell, A. N., Midland, A. A., Zawistowski, J. S., Johnson, N. L., Granger, D. A., Jordan, N. V., Darr, D. B., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.053 · Cited by 732
Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors
Araujo, J., & Logothetis, C. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.02.015 · Cited by 244
Research works printed but not linked: 70
- Lamiman, 2014, Survey of Raf kinase inhibitor protein (RKIP) in multiple cancer types, Crit. Rev. Oncog., 19, 455, 10.1615/CritRevOncog.2014011987 · DOI
- Martinho, O., Granja, S., Jaraquemada, T., Caeiro, C., Miranda-Gonçalves, V., Honavar, M., Costa, P., Damasceno, M., Rosner, M.R., and Lopes, J.M. (2012). Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas. PLoS ONE, 7. · doi:10.1371/journal.pone.0030769
- Martinho, O., Pinto, F., Granja, S., Miranda-Gonçalves, V., Moreira, M.A.R., Ribeiro, L.F.J., di Loreto, C., Rosner, M.R., Longatto-Filho, A., and Reis, R.M. (2013). RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy. PLoS ONE, 8. · doi:10.1371/journal.pone.0059104
- Yun, 2009, Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7, EMBO J., 28, 347, 10.1038/emboj.2008.294 · DOI · Paper page
- Fu, 2003, Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis, J. Natl. Cancer Inst., 95, 878, 10.1093/jnci/95.12.878 · DOI · Paper page
- Bainer, 2016, Gene expression in local stroma reflects breast tumor states and predicts patient outcome, Sci. Rep., 6, e39240, 10.1038/srep39240 · DOI
- Frankenberger, 2015, Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages, Cancer Res., 75, 4063, 10.1158/0008-5472.CAN-14-3394 · DOI
- Lee, U., Frankenberger, C., Yun, J., Bevilacqua, E., Caldas, C., Chin, S.-F., Rueda, O.M., Reinitz, J., and Rosner, M.R. (2013). A prognostic gene signature for metastasis-free survival of triple negative breast cancer patients. PLoS ONE, 8. · DOI
- Sun, 2013, HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis, Proc. Natl. Acad. Sci. USA, 110, 9920, 10.1073/pnas.1305172110 · DOI · Paper page
- Yun, 2011, Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer, EMBO J., 30, 4500, 10.1038/emboj.2011.312 · DOI · Paper page
- Yeung, 1999, Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP, Nature, 401, 173, 10.1038/43686 · DOI · Paper page
- Yesilkanal, 2014, Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: Regulation of signaling networks in cancer, Crit. Rev. Oncog., 19, 447, 10.1615/CritRevOncog.2014012000 · DOI
- Zhao, 2014, Interactions of RKIP with inflammatory signaling pathways, Crit. Rev. Oncog., 19, 497, 10.1615/CritRevOncog.2014011950 · DOI
- Lorenz, 2003, Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2, Nature, 426, 574, 10.1038/nature02158 · DOI · Paper page
- Skinner, 2014, RKIP Structure Drives Its Function: A Three-State Model for Regulation of RKIP, Crit. Rev. Oncog., 19, 483, 10.1615/CritRevOncog.2014012001 · DOI · Paper page
- Skinner, 2017, Conserved salt-bridge competition triggered by phosphorylation regulates the protein interactome, Proc. Natl. Acad. Sci. USA., 114, 13453, 10.1073/pnas.1711543114 · DOI · Paper page
- Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci. Signal., 6, pl1, 10.1126/scisignal.2004088 · DOI · Paper page
- Guo, 2013, Aberrant methylation and loss expression of RKIP is associated with tumor progression and poor prognosis in gastric cardia adenocarcinoma, Clin. Exp. Metastasis, 30, 265, 10.1007/s10585-012-9533-x · doi:10.1007/s10585-012-9533-x
- LI, 2014, Promoter methylation of Raf kinase inhibitory protein: A significant prognostic indicator for patients with gastric adenocarcinoma, Exp. Ther. Med., 8, 844, 10.3892/etm.2014.1833 · doi:10.3892/etm.2014.1833
- Guo, 2012, Decreased expression and aberrant methylation of Raf kinase inhibitory protein gene in esophageal squamous cell carcinoma, Cancer Investig., 30, 703, 10.3109/07357907.2012.732164 · doi:10.3109/07357907.2012.732164
- Wei, 2017, Promoter methylation and expression of Raf kinase inhibitory protein in esophageal squamous cell carcinoma, Oncol. Lett., 13, 1866, 10.3892/ol.2017.5617 · doi:10.3892/ol.2017.5617
- Hagan, 2008, Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability, J. Clin. Pathol., 61, 524, 10.1136/jcp.2007.046987 · doi:10.1136/jcp.2007.046987
- Minoo, 2006, Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis, Gut., 55, 1467, 10.1136/gut.2005.082859 · DOI
- Kim, 2017, Reduced RKIP Expression is Associated with Breast Neoplastic Progression and is Correlated with Poor Outcomes and Aberrant Methylation in Breast Carcinoma, Appl. Immunohistochem. Mol. Morphol. AIMM, 25, 467
- Beach, 2008, Snail is a repressor of RKIP transcription in metastatic prostate cancer cells, Oncogene, 27, 2243, 10.1038/sj.onc.1210860 · DOI · Paper page
- Labbozzetta, 2015, Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple-negative breast cancer SUM 159 cells, Oncol. Lett., 10, 3807, 10.3892/ol.2015.3787 · doi:10.3892/ol.2015.3787
- Lee, 2014, Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions, Proc. Natl. Acad. Sci. USA, 111, 364
- Ren, 2012, Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer, Cancer Res., 72, 3091, 10.1158/0008-5472.CAN-11-3546 · DOI · Paper page
- Bonavida, 2011, Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry, Nitric Oxide Biol. Chem., 24, 1, 10.1016/j.niox.2010.10.001 · DOI
- Das, 2012, Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma, Cancer Res., 72, 6217, 10.1158/0008-5472.CAN-12-0402 · doi:10.1158/0008-5472.can-12-0402
- Liang, 2012, Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis, J. Biol. Chem., 287, 33533, 10.1074/jbc.M112.392332 · DOI
- Zhang, 2012, Transcriptional regulation of RKIP expression by androgen in prostate cells, Cell Physiol. Biochem. Int. J. Exp. Cell Physiol. Biochem. Pharmacol., 30, 1340, 10.1159/000343323 · doi:10.1159/000343323
- Zhang, B., Wang, O., Qin, J., Liu, S., Sun, S., Liu, H., Kuang, J., Jiang, G., and Zhang, W. (2013). cis-Acting elements and trans-acting factors in the transcriptional regulation of raf kinase inhibitory protein expression. PLoS ONE, 8. · DOI
- Li, 2014, miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells, Mol. Cancer, 13, e193, 10.1186/1476-4598-13-193 · DOI
- Du, 2017, MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP, Cell Physiol. Biochem. Int. J. Exp. Cell Physiol. Biochem. Pharmacol., 41, 1135, 10.1159/000464120 · DOI
- Du, 2017, LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression, Oncotarget, 8, 94358, 10.18632/oncotarget.21719 · DOI
- Hatzl, 2016, Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP, Cancer Res., 76, 3644, 10.1158/0008-5472.CAN-15-3049 · DOI
- Huang, 2012, MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells, Biochem. Biophys. Res. Commun., 425, 127, 10.1016/j.bbrc.2012.07.025 · DOI
- Poma, 2012, Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinoma, Omics J. Integr. Biol., 16, 579, 10.1089/omi.2012.0048 · DOI
- Kim, 2018, Downregulation of Raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines, J. Cancer Res. Clin. Oncol., 144, 1487, 10.1007/s00432-018-2672-y · doi:10.1007/s00432-018-2672-y
- Moen, E.L., Wen, S., Anwar, T., Cross-Knorr, S., Brilliant, K., Birnbaum, F., Rahaman, S., Sedivy, J.M., Moss, S.F., and Chatterjee, D. (2012). Regulation of RKIP function by Helicobacter pylori in gastric cancer. PLoS ONE, 7. · DOI
- Wen, 2014, CDK5-mediated phosphorylation and autophagy of RKIP regulate neuronal death in Parkinson’s disease, Neurobiol. Aging, 35, 2870, 10.1016/j.neurobiolaging.2014.05.034 · DOI · Paper page
- Baritaki, 2010, Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: Inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP, Cell Cycle, 9, 4931, 10.4161/cc.9.24.14229 · DOI
- Tsao, 2009, Nitric oxide enhances expression of raf kinase inhibitor protein in keratinocytes, Exp. Dermatol., 18, 571, 10.1111/j.1600-0625.2008.00811.x · DOI
- Pasqualetti, 2011, Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines, Lung Cancer Amst. Neth., 74, 197, 10.1016/j.lungcan.2011.03.003 · DOI
- Ricciardi, 2010, Synergistic cytotoxicity and molecular interaction on drug targets of sorafenib and gemcitabine in human pancreas cancer cells, Chemotherapy, 56, 303, 10.1159/000320031 · doi:10.1159/000320031
- Giovannetti, 2013, Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cells, Curr. Pharm. Des., 19, 927, 10.2174/138161213804547268 · doi:10.2174/138161213804547268
- Chatterjee, 2004, RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis, J. Biol. Chem., 279, 17515, 10.1074/jbc.M313816200 · doi:10.1074/jbc.m313816200
- Yousuf, S., Duan, M., Moen, E.L., Cross-Knorr, S., Brilliant, K., Bonavida, B., LaValle, T., Yeung, K.C., Al-Mulla, F., and Chin, E. (2014). Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer. PLoS ONE, 9. · DOI
- Chen, 2014, Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells, J. Mol. Med. Berl. Ger., 92, 53, 10.1007/s00109-013-1083-4 · doi:10.1007/s00109-013-1083-4
- Beshir, 2011, Locostatin Disrupts Association of Raf Kinase Inhibitor Protein with Binding Proteins by Modifying a Conserved Histidine Residue in the Ligand-Binding Pocket, Forum Immunopathol. Dis. Ther., 2, 47, 10.1615/ForumImmunDisTher.v2.i1.60 · doi:10.1615/forumimmundisther.v2.i1.60
- Zhu, 2005, A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration, Chem. Biol., 12, 981, 10.1016/j.chembiol.2005.07.007 · DOI
- Shemon, A.N., Eves, E.M., Clark, M.C., Heil, G., Granovsky, A., Zeng, L., Imamoto, A., Koide, S., and Rosner, M.R. (2009). Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration. PLoS ONE, 4. · doi:10.1371/journal.pone.0006028
- Zebisch, 2012, Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia, Leukemia, 26, 1842, 10.1038/leu.2012.61 · DOI
- Caraffini, 2018, Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration, Blood, 131, 826, 10.1182/blood-2017-09-804906 · doi:10.1182/blood-2017-09-804906
- Stahl, M., Kohrman, N., Gore, S.D., Kim, T.K., Zeidan, A.M., and Prebet, T. (2016). Epigenetics in Cancer: A Hematological Perspective. PLoS Genet., 12. · DOI
- Huang, 2013, TET1 plays an essential oncogenic role in MLL-rearranged leukemia, Proc. Natl. Acad. Sci. USA., 110, 11994, 10.1073/pnas.1310656110 · DOI · Paper page
- Baritaki, 2011, Unique Pattern of Overexpression of Raf-1 Kinase Inhibitory Protein in Its Inactivated Phosphorylated Form in Human Multiple Myeloma, Forum Immunopathol. Dis. Ther., 2, 179, 10.1615/ForumImmunDisTher.v2.i2.90 · doi:10.1615/forumimmundisther.v2.i2.90
- Jazirehi, 2004, Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin’s lymphoma B cells by Rituximab, Cancer Res., 64, 7117, 10.1158/0008-5472.CAN-03-3500 · DOI · Paper page
- Vega, 2009, Dysregulation of the cell survival/anti-apoptotic NF-κB pathway by the novel humanized BM-ca anti-CD20 mAb: Implication in chemosensitization, Int. J. Oncol., 35, 1289, 10.3892/ijo_00000446 · DOI
- Baritaki, 2011, The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: Role in sensitization to TRAIL apoptosis, Int. J. Oncol., 38, 1683
- Trakul, 2005, Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation, J. Biol. Chem., 280, 24931, 10.1074/jbc.M413929200 · DOI · Paper page
- Yeung, 2000, Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein, Mol. Cell. Biol., 20, 3079, 10.1128/MCB.20.9.3079-3085.2000 · DOI · Paper page
- Yeung, 2001, Raf kinase inhibitor protein interacts with NF-κB-inducing kinase and TAK1 and inhibits NF-κB activation, Mol. Cell. Biol., 21, 7207, 10.1128/MCB.21.21.7207-7217.2001 · DOI · Paper page
- Grimaldi, 2017, MEK Inhibitors in the Treatment of Metastatic Melanoma and Solid Tumors, Am. J. Clin. Dermatol., 18, 745, 10.1007/s40257-017-0292-y · DOI
- Battula, 2017, IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells, Oncotarget, 8, 36936, 10.18632/oncotarget.16294 · DOI
- Andela, 2000, Tumor Metastasis and the Reciprocal Regulation of Prometastatic and Antimetastatic Factors by Nuclear Factor κB, Cancer Res., 60, 6557
- Golubovskaya, 2014, Targeting FAK in human cancer: From finding to first clinical trials, Front. Biosci. Landmark Ed., 19, 687, 10.2741/4236 · DOI · Paper page
- Noy, 2014, Tumor-associated macrophages: From mechanisms to therapy, Immunity, 41, 49, 10.1016/j.immuni.2014.06.010 · DOI · Paper page
- Ideker, 2011, Boosting signal-to-noise in complex biology: Prior knowledge is power, Cell, 144, 860, 10.1016/j.cell.2011.03.007 · DOI · Paper page
Cited by
Lee, J., Olivieri, C., Ong, C., Masterson, L. R., Gomes, S., Lee, B.-S., Schaefer, F., Lorenz, K., Veglia, G., & Rosner, M. R. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121867119 · Cited by 20
Self-citationOlivieri, C., Biancaniello, C., Manu, V. S., Walters, M. S., Masterson, L., Rosner, M. R., De Simone, A., & Veglia, G. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169466 · Cited by 2
Self-citation
Metadata
- Authors
- Yesilkanal, A. E., & Rosner, M. R.
- Affiliations
- Ben May Department for Cancer Research, University of Chicago, Chicago, IL 60637, USA
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2018-09-04
- Volume
- 10
- Issue
- 9
- Pages
- 306
- ISSN
- 2072-6694
- Cited by
- 48
- References
- 2
- Language
- en
- Funders
- National Institutes of Health (R01CA184494, R01GM121735)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting Raf Kinase Inhibitory Protein Regulation and Function. https://app.cochat.ai/papers/10.3390/cancers10090306
- The paper
- Yesilkanal, A. E., & Rosner, M. R. (2018). Targeting Raf Kinase Inhibitory Protein Regulation and Function. Cancers. https://doi.org/10.3390/cancers10090306
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.